Bio Essence Signs Deal With Zhituo to Develop AI Assistants for Healthcare Practitioners

Bio Essence signed a technology development agreement with Zhituo Software to integrate practitioner-specific artificial intelligence into its MediFlow platform. The technology will let authorized healthcare and wellness practitioners create private AI assistants using their own professional materials. Bio Essence will own the developed technology, subject to limited rights for approved third-party and pre-existing components. Completion and delivery are scheduled by December 15, 2026, subject to testing and acceptance. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bio Essence Corp. published the original content used to generate this news brief via (Ref. ID: 202610150800ACCESSWRNAPR_____1237027) on October 15, 2026, and is solely responsible for the information contained therein. (C)